142 related articles for article (PubMed ID: 36639265)
21. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
Li GH; Yu JH; Yang B; Gong FC; Zhang KW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
[TBL] [Abstract][Full Text] [Related]
22. LncRNA SNHG16 Promotes Hepatocellular Carcinoma Proliferation, Migration and Invasion by Regulating miR-186 Expression.
Chen H; Li M; Huang P
J Cancer; 2019; 10(15):3571-3581. PubMed ID: 31293662
[TBL] [Abstract][Full Text] [Related]
23. lncRNA SNHG16 Mediates Cell Proliferation and Apoptosis in Cholangiocarcinoma by Directly Targeting miR-146a-5p/GATA6 Axis.
Wu T; Lei MS; Gao XZ; Xiong TG; Yang K; Gong Q; Tang R; Tian YP; Fu XH
Biochem Genet; 2021 Oct; 59(5):1311-1325. PubMed ID: 33797690
[TBL] [Abstract][Full Text] [Related]
24. LncRNA SNHG16 induces the SREBP2 to promote lipogenesis and enhance the progression of pancreatic cancer.
Yu Y; Dong JT; He B; Zou YF; Li XS; Xi CH; Yu Y
Future Oncol; 2019 Nov; 15(33):3831-3844. PubMed ID: 31664866
[No Abstract] [Full Text] [Related]
25. LncRNA SNHG16 contributes to osteosarcoma progression by acting as a ceRNA of miR-1285-3p.
Xiao X; Jiang G; Zhang S; Hu S; Fan Y; Li G; Yu H; He S
BMC Cancer; 2021 Apr; 21(1):355. PubMed ID: 33823834
[TBL] [Abstract][Full Text] [Related]
26. LncRNA SNHG16 sponges miR-98-5p to regulate cellular processes in osteosarcoma.
Liao S; Xing S; Ma Y
Cancer Chemother Pharmacol; 2019 Jun; 83(6):1065-1074. PubMed ID: 30923843
[TBL] [Abstract][Full Text] [Related]
27. LncRNA SNHG16 regulates trophoblast functions by the miR-218-5p/LASP1 axis.
Yu Z; Zhang Y; Zheng H; Gao Q; Wang H
J Mol Histol; 2021 Oct; 52(5):1021-1033. PubMed ID: 34110517
[TBL] [Abstract][Full Text] [Related]
28. SNHG16 contributes to breast cancer cell migration by competitively binding miR-98 with E2F5.
Cai C; Huo Q; Wang X; Chen B; Yang Q
Biochem Biophys Res Commun; 2017 Apr; 485(2):272-278. PubMed ID: 28232182
[TBL] [Abstract][Full Text] [Related]
29. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis.
Liu X; Yao W; Xiong H; Li Q; Li Y
Cancer Biomark; 2020; 29(2):277-290. PubMed ID: 32675392
[TBL] [Abstract][Full Text] [Related]
30. NRAS Contributes to Retinoblastoma Progression Through SNHG16/miR-183-5p/NRAS Regulatory Network.
Sun G; Su G; Liu F; Han W
Onco Targets Ther; 2019; 12():10703-10715. PubMed ID: 31827328
[TBL] [Abstract][Full Text] [Related]
31. The effects of hsa_circ_0000517/miR-326 axis on the progression of breast cancer cells and the prediction of miR-326 downstream targets in breast cancer.
Yu J; Li F; Li Y; Li Z; Jia G; Ding B; Zhou Y
Pathol Res Pract; 2021 Nov; 227():153638. PubMed ID: 34619576
[TBL] [Abstract][Full Text] [Related]
32. lncRNA DANCR Promotes Proliferation and Metastasis of Breast Cancer Cells Through Sponging miR-4319 and Upregulating VAPB.
Jia H; Liang K; Liu G; Zhang Z; Shi Y; Liang H; Liu P
Cancer Biother Radiopharm; 2022 Oct; 37(8):650-661. PubMed ID: 32818383
[No Abstract] [Full Text] [Related]
33. Long non-coding RNA SNHG16 regulates human aortic smooth muscle cell proliferation and migration via sponging miR-205 and modulating Smad2.
Lin Y; Tian G; Zhang H; Yuan W; Xie Y; Yang Y; Wang J; Liang Y
J Cell Mol Med; 2019 Oct; 23(10):6919-6929. PubMed ID: 31441592
[TBL] [Abstract][Full Text] [Related]
34. Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma.
Xie X; Xu X; Sun C; Yu Z
Exp Cell Res; 2019 Oct; 383(1):111501. PubMed ID: 31306653
[TBL] [Abstract][Full Text] [Related]
35. SNHG16 promotes the progression of osteoarthritis through activating microRNA-93-5p/CCND1 axis.
Cheng W; Hao CY; Zhao S; Zhang LL; Liu D
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9222-9229. PubMed ID: 31773673
[TBL] [Abstract][Full Text] [Related]
36. PCMT1 is a potential target related to tumor progression and immune infiltration in liver cancer.
Liu J; Liu B; Li Y; Mi Z; Tan H; Rong P
Eur J Med Res; 2023 Aug; 28(1):289. PubMed ID: 37596654
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
[TBL] [Abstract][Full Text] [Related]
38. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
Ding L; Xie Z
Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
[TBL] [Abstract][Full Text] [Related]
39. Lnc-SNHG16/miR-128 axis modulates malignant phenotype through WNT/β-catenin pathway in cervical cancer cells.
Wu W; Guo L; Liang Z; Liu Y; Yao Z
J Cancer; 2020; 11(8):2201-2212. PubMed ID: 32127947
[No Abstract] [Full Text] [Related]
40. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway.
Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
